Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Neutralizing antibodies produced following COVID-19 BNT162b2 vaccine found to activate complement cascade

Neutralizing antibodies produced following COVID-19 BNT162b2 vaccine found to activate complement cascade

Longitudinal and proteome-wide analysis of antibodies in COVID-19 patients using a SARS-CoV-2 proteome microarray

Longitudinal and proteome-wide analysis of antibodies in COVID-19 patients using a SARS-CoV-2 proteome microarray

The generation of SARS-CoV-2 virus-like particles in insect cells

The generation of SARS-CoV-2 virus-like particles in insect cells

Development of prioritization tool to further the role of equity in global COVID-19 vaccine allocation

Development of prioritization tool to further the role of equity in global COVID-19 vaccine allocation

Higher vaccination coverage associated with lower rates of population-level COVID-19 mortality and incidence in the US

Higher vaccination coverage associated with lower rates of population-level COVID-19 mortality and incidence in the US

SARS-CoV-2-specific T cells are broader after vaccination than after infection

SARS-CoV-2-specific T cells are broader after vaccination than after infection

Study finds 67% of individuals with long COVID are developing dysautonomia

Study finds 67% of individuals with long COVID are developing dysautonomia

SARS-CoV-2 viral shedding varies widely in asymptomatic and mildly ill patients

SARS-CoV-2 viral shedding varies widely in asymptomatic and mildly ill patients

Can fractional doses of COVID-19 vaccines protect against SARS-CoV-2?

Can fractional doses of COVID-19 vaccines protect against SARS-CoV-2?

Antibody cocktail shows synergetic effects against SARS-CoV-2 Omicron in vitro and in vivo

Antibody cocktail shows synergetic effects against SARS-CoV-2 Omicron in vitro and in vivo

SARS-CoV-2 Mpro inhibitors built on rattlesnake venom scaffold

SARS-CoV-2 Mpro inhibitors built on rattlesnake venom scaffold

Probenecid shows activity against respiratory syncytial virus

Probenecid shows activity against respiratory syncytial virus

Exploring happy hypoxia in COVID-19 patients

Exploring happy hypoxia in COVID-19 patients

Safety and immunogenicity of three-dose vaccination with the Pfizer/BioNtech SARS-CoV-2 mRNA vaccine

Safety and immunogenicity of three-dose vaccination with the Pfizer/BioNtech SARS-CoV-2 mRNA vaccine

Poor asthma control triggered by SARS-CoV-2

Poor asthma control triggered by SARS-CoV-2

Study evaluates hybridization probe capture for enriching coronavirus genomic material in bat oral and rectal swabs

Study evaluates hybridization probe capture for enriching coronavirus genomic material in bat oral and rectal swabs

Identifying the immunological correlate of protection to predict the efficacy of new coronavirus vaccines

Identifying the immunological correlate of protection to predict the efficacy of new coronavirus vaccines

Clinical characteristics of immunocompromised patients infected with the SARS-CoV-2 Omicron variant

Clinical characteristics of immunocompromised patients infected with the SARS-CoV-2 Omicron variant

Artificial circular RNAs found to bypass cellular antiviral responses

Artificial circular RNAs found to bypass cellular antiviral responses

Chimeric Delta-Omicron RBD-dimer vaccine found to be effective against SARS-CoV-2 variants

Chimeric Delta-Omicron RBD-dimer vaccine found to be effective against SARS-CoV-2 variants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.